<DOC>
	<DOCNO>NCT01013181</DOCNO>
	<brief_summary>The purpose study review chart first 100 patient include french compassionate program include patient Immune Thrombopenia receive romiplostim .</brief_summary>
	<brief_title>Safety Efficacy Romiplostim Immune Thrombocytopenia ( ITP ) `` Real-life `` : Result French Experience 72 Adults</brief_title>
	<detailed_description>Inclusion Criteria : - Subject diagnosis ITP accord American Society Hematology guideline ( George et al. , 1996 ) . - Subject equal great 18 year age . - Before study-specific procedure , appropriate write informed consent must obtain . - Subject receive romiplostim compassionate program - Available follow-up one-year Exclusion Criteria : â€¢Secondary ITP e.g : thrombopenia related hepatitis C , HIV , Chronic Lymphocytic Leukemia ... The goal study review retrospectively chart 100 first patient include program France period January 2008 July 2008 .</detailed_description>
	<mesh_term>Thrombocytopenia</mesh_term>
	<criteria>Subject diagnosis ITP accord American Society Hematology guideline ( George et al. , 1996 ) . Subject equal great 18 year age . Before studyspecific procedure , appropriate write informed consent must obtain . Secondary ITP</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>Immune Thrombopenia</keyword>
	<keyword>Thrombocytopenia</keyword>
	<keyword>romiplostim</keyword>
	<keyword>compassionate program</keyword>
</DOC>